Immix Biopharma, Inc. (IMMX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-05-29

Immix Biopharma, Inc. (IMMX) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-29. 3 Form 8-K material event filings were reported by IMMX in the last 90 days. InsiderAlpha tracks every IMMX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Immix Biopharma, Inc. (IMMX)

SEC CIK	0001873835

90-Day SEC Filing Activity

Form 4 filings (90d)	9
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-05-29

Recent IMMX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-05-22	BUCHAN JANE	Director	A — Grant or award	6.2K	$0.00	—	SEC
2026-05-22	Adams Helen C.	Director	A — Grant or award	6.2K	$0.00	—	SEC
2026-05-22	Ng Carey	Director	A — Grant or award	6.2K	$0.00	—	SEC
2026-05-22	Marquet Magda	Director	A — Grant or award	6.2K	$0.00	—	SEC
2026-05-22	CHANG NANCY T	Director	A — Grant or award	6.2K	$0.00	—	SEC
2026-05-22	Chudnovsky Yekaterina	Director	A — Grant or award	6.2K	$0.00	—	SEC
2026-05-22	Hsu Jason	Director	A — Grant or award	6.2K	$0.00	—	SEC
2025-12-10	Morris Gabriel S	CFO	P — Open-market purchase	770	$6.58	$5K	SEC
2025-12-10	Rachman Ilya M	CEO and Chairman	P — Open-market purchase	746	$6.67	$5K	SEC
2025-12-08	Morris Gabriel S	CFO	J — Other acquisition / disposition	156.0K	$0.80	$125K	SEC
2025-09-17	Rachman Ilya M	CEO and Chairman	P — Open-market purchase	2.5K	$2.02	$5K	SEC
2025-09-16	Morris Gabriel S	CFO	P — Open-market purchase	2.6K	$1.97	$5K	SEC
2024-12-23	Hsu Jason	Director	P — Open-market purchase	40.0K	$2.19	$88K	SEC
2024-12-20	Hsu Jason	Director	P — Open-market purchase	7.7K	$2.17	$17K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Immix Biopharma, Inc. (IMMX). Updated in real time as new filings are submitted to the SEC.

Most-Active IMMX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
BUCHAN JANE	2	—
Adams Helen C.	2	—
Ng Carey	2	—
CHANG NANCY T	2	—
Chudnovsky Yekaterina	2	—

Recent IMMX Form 8-K Material Events

2026-05-29 — Item 5.07 [SEC]
2026-05-21 — Item 8.01, 9.01 [SEC]
2026-05-21 — Item 7.01, 8.01, 9.01 [SEC]
2026-03-30 — Item 7.01, 8.01, 9.01 · Clinical · positive [SEC]
Immix Biopharma announced that enrollment is complete for its NEXICART-2 clinical trial of NXC-201, with topline results expected in Q3 2026. This represents a key milestone in the trial's progression toward data readout.
2026-03-25 — Item 1.01, 9.01 · Financing · neutral [SEC]
Immix Biopharma amended its At The Market (ATM) offering agreement with Citizens JMP Securities to increase the aggregate offering price to $100,000,000. The amendment expands the company's ability to raise capital through opportunistic equity sales under its existing Form S-3 re

Recent Insider Filings

2026-05-29 — Adams Helen C. (Director)
2026-05-29 — Ng Carey (Director)
2026-05-29 — Marquet Magda (Director)
2026-05-29 — Morris Gabriel S (CFO, President)
2026-05-29 — CHANG NANCY T (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in IMMX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

IMMX Insider Trading — FAQ

What is the latest insider trade for IMMX?: Immix Biopharma, Inc. (IMMX) had 9 insider filings in the last 90 days, with the most recent on 2026-05-29. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying IMMX stock?: 0 insider purchases of IMMX were filed in the last 90 days.
How many insiders are selling IMMX stock?: 0 insider sales of IMMX were filed in the last 90 days.
Where can I see IMMX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every IMMX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live IMMX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.